Delivery Order SPE2DB24D2205-SPE2DB25FEFVJ
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for RHOFADE 1% Cream 30GM under a firm fixed-price contract. The award, issued on July 30, 2025, carries a ceiling value of $2,424.79 and is scheduled for ultimate completion by July 31, 2025. This non-competitive delivery order represents a small-value pharmaceutical procurement executed from the company's existing contract vehicle to support federal medical supply requirements. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for RHOFADE 1% Cream 30GM with a ceiling value of $1,482.19 under a firm fixed-price contract type. The award was made on September 17, 2025, with an ultimate completion date of September 18, 2025. This non-set-aside competitive award represents a single delivery transaction for a branded topical pharmaceutical product to be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania....
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RHOFADE 1% Cream 30GM, a prescription medication, with a ceiling value of $2,537.16 and a completion date of December 30, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,143.78 firm fixed-price delivery order is for the supply of RHOFADE 1% Cream, a prescription medication. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RHOFADE 1% CREAM 30GM, with a ceiling value of $1,602.42 and a performance period ending on June 11, 2025. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $3,878.54, is for the delivery of RHOFADE 1% Cream 30GM. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is April 15, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a competitive delivery order valued at $1,329.35 on September 15, 2025, for the supply of Rhofade 1% Cream in a 30-gram quantity. The contract carries a firm fixed price structure with an ultimate completion date of September 16, 2025, and was funded through the Defense Logistics Agency's Medical Supply Chain, which supports pharmaceutical procurement for military and...
- This federal contract award is for the delivery of RHOFADE 1% CREAM 30GM to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $1,488.72 and a completion date of December 10, 2024. The contract is not designated with any set-aside requirements, indicating open competition....
- This federal contract award, valued at $2,533.43, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of RHOFADE 1% CREAM 30GM, a pharmaceutical product, and has an ultimate completion date of February 6, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
- This federal contract award, valued at $2,681.42, is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of RHOFADE 1% CREAM 30GM, a pharmaceutical product, and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEFVJDelivery Order
The U.S. Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of RHOFADE 1% Cream in 30-gram quantities. This is a firm fixed-price delivery order with a ceiling value of $1,143.78 and an ultimate completion date of August 6, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply agreement valued through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems. The company maintains an extensive portfolio of federal contract awards covering a broad spectrum of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, and specialized healthcare commodities. This specific delivery order for RHOFADE cream supports the Defense Logistics Agency's medical supply chain requirements for military healthcare programs. The Defense Logistics Agency is currently planning to transition to Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning vendors like AmerisourceBergen to continue serving defense healthcare customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/5/25 |